Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle

Rodney Taylor, KJ Drummond, G Salkeld, SD Sullivan

    Research output: Contribution to journalArticle

    154 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)972-975
    Number of pages4
    JournalBritish Medical Journal
    Volume329
    DOIs
    Publication statusPublished - 31 Dec 2004

    Cite this